Overview

A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted to 1. assess whether SLM0807 alters pharmacodynamics of HKB0701 2. estimate the pharmacodynamics of HKB0701 after multiple administration of CJ30001 and multiple co-administration of HKB0701/SLM0807 in healthy subject
Phase:
Phase 1
Details
Lead Sponsor:
CJ HealthCare Corporation
HK inno.N Corporation